Form 8806 - Jazz Pharmaceuticals, Inc.


Name and address of the reporting corporation:

Jazz Pharmaceuticals, Inc.
3180 Porter Drive
Palo Alto, CA  94304

Date of transaction:


Description of the transaction

Jaguar Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of Jazz Pharmaceuticals plc, merged with and into Jazz Pharmaceuticals, Inc., with Jazz Pharmaceuticals, Inc. as the surviving corporation becoming a wholly-owned subsidiary of Jazz Pharmaceuticals plc.  At the effective time of the merger, each share of Jazz Pharmaceuticals, Inc. common stock then issued and outstanding was cancelled and automatically converted into and became the right to receive one ordinary share of Jazz Pharmaceuticals plc.

Did the reporting corporation’s shareholders receive any stock or other property in exchange for their stock in  the reporting corporation, for which the reporting corporation has reasonably determined that the shareholders are required to recognize gain (if any).from the exchange of such stock?


Fair market value of the stock or other property received

$46.64 per share

Description of the stock or other property received

Ordinary shares in Jazz Pharmaceuticals plc